Jessica Snow
Operationeel Directeur bij 2SEVENTY BIO, INC.
Vermogen: 235 281 $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Jessica Snow
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 33 | |
| Public Company | Pharmaceuticals: Major | 18 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jessica Snow via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Public Communications Contact Chief Tech/Sci/R&D Officer Director/Board Member Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard Medical School | College/University | Director/Board Member Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Chief Executive Officer Chairman Director/Board Member | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree Doctorate Degree | |
| Bentley University | College/University | Graduate Degree Undergraduate Degree | |
| Wesleyan University | College/University | Undergraduate Degree Undergraduate Degree | |
| ALLOVIR, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
| PRIME MEDICINE, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ABIOMED, INC. | Medical Specialties | Investor Relations Contact Director of Finance/CFO | |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director/Board Member | |
| The Fuqua School of Business | College/University | Masters Business Admin Masters Business Admin | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree | |
| New York University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Susquehanna University | College/University | Undergraduate Degree | |
| ENTRADA THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| GLAUKOS CORPORATION | Medical Specialties | Director/Board Member | |
Wylei, Inc.
 Wylei, Inc. Packaged SoftwareTechnology Services Wylei, Inc. develops cloud-based automated engagement technologies for digital direct marketing. The firm offers behavioral tracking and analysis through web, mobile, and email; market research studies; automated customer preference detection; emails to the moment of open; animated countdown timers and device-centric formatting. The company was founded by Ken Kozaczka in 2013 and is headquartered in Jersey City, NJ. | Packaged Software | Director/Board Member | |
| University of Michigan | College/University | Masters Business Admin | |
National Resilience, Inc.
 National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member | |
| Ball State University (Indiana) | College/University | Undergraduate Degree | |
State Bar of Michigan
 State Bar of Michigan Miscellaneous Commercial ServicesCommercial Services State Bar of Michigan is a professional organization that provides a wide range of services to its members, including career center, employment, ethics helpline, and resources. State Bar of Michigan is based in Lansing, MI. The organization also offers legal assistance to the public, including lawyer referral service, legal aid programs, and probate information. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Indiana University Maurer School of Law | College/University | Graduate Degree | |
Ignited LLC
 Ignited LLC Advertising/Marketing ServicesCommercial Services Ignited LLC provides advertising services. It offers integrated strategic planning, creative, digital, experiential, media planning and buying and social media services. The company was founded by Eric A. Johnson in 1999 and is headquartered in El Segundo, CA. | Advertising/Marketing Services | Chief Executive Officer | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | President | |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded in March 1991 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Georgetown University | College/University | Undergraduate Degree | |
Servier Pharmaceuticals LLC
 Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018. | Pharmaceuticals: Major | Director/Board Member | |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Human Resources Officer |
Statistieken
Internationaal
| Verenigde Staten | 48 |
| Zwitserland | 2 |
| Nederland | 2 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 16 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 111 |
| Corporate Officer/Principal | 92 |
| Independent Dir/Board Member | 48 |
| Undergraduate Degree | 35 |
| Chairman | 25 |
Sterkste connecties
| Insiders | |
|---|---|
| Daniel Lynch | 32 |
| Mary Lynne Hedley | 25 |
| Denice Torres | 19 |
| David Schenkein | 18 |
| William R. Sellers | 14 |
| Gina Consylman | 14 |
| Jeffrey Walsh | 14 |
| Nick Leschly | 14 |
| Sarah Glickman | 13 |
| James Mandell | 13 |
| Douglas A. Melton | 11 |
| Alison Finger | 11 |
| Stephanie Fagan | 11 |
| Elisabeth Leiderman | 10 |
| Marcela Maus | 10 |
- Beurs
- Insiders
- Jessica Snow
- Bedrijfsconnecties
